Phase III, multicenter, open-label, long-term study of the safety of abatacept in Japanese patients with rheumatoid arthritis and an inadequate response to conventional or biologic disease-modifying antirheumatic drugs.
about
An effective medical partnership in Nagasaki, Japan for patients with rheumatoid arthritis.Negative pressure wound therapy and skin grafting for necrotizing fasciitis in a patient with rheumatoid arthritis treated with abatacept: A case report.Co-stimulation Therapy in Rheumatoid Arthritis: Today and Tomorrow.Peptide ligand structure and I-Aq binding avidity influence T cell signaling pathway utilization.Whole genome analysis on the genetic backgrounds associated with the secondary failure to etanercept in patients with rheumatoid arthritis.
P2860
Phase III, multicenter, open-label, long-term study of the safety of abatacept in Japanese patients with rheumatoid arthritis and an inadequate response to conventional or biologic disease-modifying antirheumatic drugs.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Phase III, multicenter, open-l ...... modifying antirheumatic drugs.
@ast
Phase III, multicenter, open-l ...... modifying antirheumatic drugs.
@en
Phase III, multicenter, open-l ...... modifying antirheumatic drugs.
@nl
type
label
Phase III, multicenter, open-l ...... modifying antirheumatic drugs.
@ast
Phase III, multicenter, open-l ...... modifying antirheumatic drugs.
@en
Phase III, multicenter, open-l ...... modifying antirheumatic drugs.
@nl
prefLabel
Phase III, multicenter, open-l ...... modifying antirheumatic drugs.
@ast
Phase III, multicenter, open-l ...... modifying antirheumatic drugs.
@en
Phase III, multicenter, open-l ...... modifying antirheumatic drugs.
@nl
P2093
P2860
P1433
P1476
Phase III, multicenter, open-l ...... modifying antirheumatic drugs.
@en
P2093
Ami Yamamoto
Eiichi Suematsu
Japan Abatacept Study Group
Nobuyuki Miyasaka
Shigeru Honjo
Shuji Ohta
Tsukasa Matsubara
Yukitomo Urata
P2860
P304
P356
10.3109/14397595.2014.899179
P577
2014-04-23T00:00:00Z